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ABSTRACT
Objective: This study was to investigate the effect of analog rice (AR) on glucagon-like peptide-1 (GLP-1) and insulin serum levels, glucose transporter-2 
(GLUT-2) expression, and fasting blood glucose (FBG) level in diabetic rats. 
Methods: Fifty male Wistar rats divided into the control group (n=10) and the experimental group. High-fat diet and streptozotocin were administered 
in experimental groups, which then divided into four equal groups (n=10, each) (negative control group, rice group, AR1 and AR2 group, given standard 
pellet, rice pellet, AR1 and AR2 pellet, respectively, for 6 weeks). GLP-1 and insulin serum levels were measured by enzyme-linked immunosorbent 
assay. The expression of GLUT-2 and the number of pancreatic β-cells observed using an immunohistochemistry method. 
Results: FBG levels in the AR1 and AR2 groups decreased, while the rice group remained. GLP-1 serum levels of the negative control and rice 
groups were not significantly different from the control group, while the AR1 and AR2 groups higher than the control group (p≤0.05). All the 
treatment groups had insulin serum levels significantly lower than control group (p≤0.05), except the AR1 group. The expression of GLUT-2 and 
the number of pancreatic β-cells in the treatment groups were less than the control group, but between treatment groups were not significantly 
different.
Conclusion: AR significantly effective in reducing FBG level in diabetic rats through stimulation of increased GLP-1 and insulin serum levels serum 
levels but AR did not affect on the expression of GLUT-2.
Keywords: Analog rice, Resistant starch, Glucagon-like peptide-1, Insulin, Glucose transporter-2, β-cell.
INTRODUCTION
Diabetes mellitus (DM) prevalence worldwide increased by 11% within 
4 years. In 2013, the number of diabetic patients was 381.8 million [1] and 
increased to 425 million in 2017 [2,3]. It is estimated that DM patients 
in the world will reach 591.9 million in 2035 [1,2]. DM is a troubling 
disease because it causes many complications, both acute and chronic. 
Such complications include stroke, heart failure, kidney failure, sexual 
dysfunction, cataracts, and gangrene [2,4].
DM management needs to integrate the drug therapy [5], diet [6,7], 
exercise [7,8], and possible complementary treatments [9]. The 
successful management of DM is influenced by lifestyle [7,9], includes 
eating habits [4,6,7]. Most of the world’s population has eating habits 
using easily absorbed foods, rich in carbohydrates, low in fiber, and 
resistant starch (RS), such as rice. DM patients who consume rice as a 
staple food can result in suboptimal control of blood glucose [10]. This 
can contribute to therapeutic failure of DM; therefore, we need to find a 
substitute staple food.
Analog rice (AR) can be considered as an alternative diet management 
for diabetic patients. AR is artificial rice which has adjustable 
composition according to the needs. It can contain high RS and high-
fiber ingredients. Former studies reported that high-fiber diet could 
improve blood glucose control and attenuate hyperinsulinemia in 
DM type 2 patients [6,11]. Therefore, this study was to analyze the 
mechanism of blood glucose improvement after AR consumption in 
diabetic rat model.
METHODS
Ethical clearance was obtained from the Animal Care and Use Committee 
Veterinary Faculty, Airlangga University, No. 667-KE/2017.
Making rice pellets, AR, and AR pellets
Rice pellet was made by substituting 60% of carbohydrate content of 
standard pellet with rice (IR 64). AR was produced using hot extruder 
technology with twin screws [12]. The compositions are found in 
Table 1. There are two types of AR, each named AR 1 and AR 2. AR 
pellets were made by substituting 60% of carbohydrate content from 
standard pellets with each type of AR. All the pellets have the same 
calories (iso calories).
Rat preparation
A total of 55 rats Wistar strain, 3 months old, body weight 160–200 g, 
were randomly divided into control group (n=10) and experimental 
group (n=45). The control group was fed with standard feed formula 
for 3 weeks, whereas the experimental group was fed with high-fat 
diet (HFD) containing 23% fat (lard fat) for 3 weeks and injected with 
streptozotocin (STZ) (BioWORLD) 35 mg/kg intraperitoneal at the end 
of the 2nd week (14th day). The STZ was dissolved in citrate buffer (0.05 
M, pH 4.5) [13,14]. At the end of the 3th week of HFD administration 
(21th) or After 7 day of injection of STZ. FBG levels of all the rats were 
measured through the tip of the rats tail [13,14], using glucometer 
(Easy Touch, Taiwan). The experimental group which had fasting blood 
glucose (FBG) levels between 300–450 mg/dl was randomly divided 
into four equal groups, each of 10 rats per group, namely: (1) Negative 
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control group: Fed with standard pellets; (2) rice group: Fed with rice 
pellets; (3) AR1 group: Fed with AR1 pellets; and (4) AR2 group: Fed 
with AR2 pellets. Each pellet was given ad libitum for 6 weeks. At the 
end of the 6th week, after being pellets provisioning, the rats were fasted 
for 8 h then measured blood glucose level using glucometer. Moreover, 
the rats were terminate; then, the blood and pancreas were taken for 
the measurement of research parameters.
Research parameters measurement
FBG levels were measured from 8-h fasting rats using glucometer. 
Glucagon-like peptide-1 (GLP-1) serum levels were measured by the 
enzyme-linked immunosorbent assay (ELISA) method using rat GLP-
1 ELISA assay kit (produced by Novateinbio). Data were expressed 
as ng/ml. Insulin serum levels were measured by the ELISA method, 
using rat insulin ELISA assay kit (produced by Novateinbio). Data 
were expressed as μIU/ml. Immunohistochemistry analysis of the 
expression of glucose transporter-2 (GLUT-2) and the number of 
pancreatic β-cells used single-stain monoclonal antibody. Expression 
of GLUT-2 was calculated from cell that contains GLUT-2 bonds with 
GLUT-2 monoclonal antibodies. Pancreatic β-cells with purple color 
were scored for the presence of GLUT-2 with brown color. It was 
quantitatively measured by counting on 10 selected high-power fields 
(×400) using light microscope.
RESULTS
Rice (original rice) does not contain RS. Meanwhile, AR1 and AR2, each 
has 16.83% and 11.46% RS (Table 2). AR has 4 times higher in fiber 
content than original rice. Among them, AR1 has the highest fiber which 
is 1.77%.
FBG level
There was no difference in pre-induction the FBG level between groups. 
Post-induction FBG level of the control group did not change, whereas 
post-induction FBG level of the experimental groups has increased, 
but there was no significant difference on FBG levels between the 
experimental groups. After 6 weeks of diet therapy, the FBG of control 
group was 94.95±0.51 mg/dl. The FBG level in the control negative and 
rice groups did not differ significantly, while the AR1 and AR2 groups 
decreased significantly.
The GLP-1 and insulin serum levels
The mean of GLP-1 serum level of control group was 46.09±4.3 ng/ml. 
The mean of GLP-1 serum levels of negative control and rice groups 
did not differ significantly with control group (p≤0.05), while AR1 
and AR2 groups increased significantly. The GLP-1 serum level AR1 
group was higher than AR2 group but was not significantly. The mean 
insulin serum level in the control group was 136.21±17.4 μIU/ml. All 
experimental groups had significantly lower serum insulin levels than 
the control group (p≤0.05), except AR1 group. AR1 and AR2 groups had 
significantly higher serum insulin levels than rice group.
The expression of GLUT-2 and the number of pancreatic β-cells
Observations on β-cells in the islets of Langerhans showed that 
experimental groups had pancreatic β-cells damaged so that the 
number of the cells less than the control group significantly. The 
diameter or the area islets of Langerhans of experimental groups 
was shorter or narrower than control group. Expression of GLUT-2 of 
pancreatic β-cells was not different significantly between experimental 
groups.
DISCUSSION
The effects of AR on GLP-1 serum level in diabetic rats
The GLP-1 serum level on negative control group and rice group was not 
different from the control group. This indicates that the administration 
of HFD and STZ did not affect in significant changes on GLP-1 serum 
level and the administration of rice for 6 weeks has not been shown to 
significantly increase GLP-1 serum levels. These results indicated that 
GLP-1 serum level in diabetes was normal and administration of rice 
did not increase GLP-1 serum level (Table 3).
The administration of AR for 6 weeks has been shown to increase GLP-
1 serum levels significantly. This effect occurs because AR has a high 
RS and fiber. Correlation test showed a significant relationship between 
GLP-1 serum level with RS (0.736) and fiber (0.733). RS and fiber inhibit 
the digestion and absorption of food in the intestine and accelerating 
the onset of satiety [11,15,16]. This effect leads to the stimulation of L 
cells in the intestine to secrete GLP-1 [17].
The RS [18,19] and fiber [10] cannot be digested; then, it will be 
fermented by the microbiota in the intestine [18-20] and generated 
short-chain fatty acid (SCFA) [17,20]. SCFA can stimulate intestinal L 
cells which result in an increase on GLP-1 secretion of the cells [17,18]. 
The results of another study showed that administration of an acute 
a fiber-rich diet had no effect on plasma levels of GLP-1 [21]. In this 
study, diabetic rats were given AR which rich in fiber for 6 weeks. The 
results showed different effects, fiber has a strong effect on increasing 
GLP-1 serum levels. This fact suggests that the provision of fiber has 
increasing effect on GLP-1 level if given repeatedly. The provision of 
fiber takes a long time to increase in GLP-1 serum level. AR1 is stronger 
than AR2 to increase GLP-1 serum levels due to higher levels of RS and 
fiber.
The effects of AR on the expression of GLUT-2 and the number of 
pancreatic β-cells
The results obtained in this study indicate that an increase in GLP-1 
serum level in the AR1 and AR2 group was not followed by an increase 
in expression of GLUT-2 and number (total) of pancreatic β-cells 
(Table 4).
Table 4 shows that the amount of pancreatic beta-cells which expressing 
GLUT-2 in the experimental group did not differ significantly from the 
Table 1: The composition of analog rice
Ingredient AR1 AR2
Modified cassava flour 16.2 32.4
Rice flour 21.6 5.4
Cornstarch 16.2 16.2
Soy protein 3.9 3.9
Palm oil 1.4 2.1
Sodium alginate 0.7 0.0
Total 60.0 60.0
AR1: Analog rice 1, AR2: Analog rice 2, MOCAF produced by PT Bangkit Cassava 
Mandiri, Indonesia. Produced from fermented cassava and then made into 
flour [12]. All measured in g. MOCAF: Modified cassava flour
Table 2: Calorie, fiber, and RS content in 100 g analog rice
Description Calorie (cal) Fiber (g) RS (g)
Rice 398.4 0.41 0,00
AR1 382.7 1.77 16.83
AR2 379.8 0.86 11.46
RS: Resistant starch, AR1: Analog rice 1, AR2: Analog rice 2. Calorie was 
measured in calorie. Fiber and RS were measured in g
Table 3: GLP-1 and insulin serum levels
Group GLP-1 Insulin
Control 46.09±04.3 136.21±17.4




n=10, values are given as mean±SD, GLP-1: Glucagon-like peptide-1 was 
measured in ng/ml, insulin was measured in μIU/ml, AR1: Analog rice 1, 
AR2: Analog rice 2. SD: Standard deviation
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control group. Since GLP-1 serum levels in the AR1 and AR2 groups 
increased, but GLUT-2 expression and the number of β-cells of pancreas 
were not different (not change) compared to the negative control group, 
we suspected that GLP-1 had no stimulating effect on GLUT-2 expression 
and pancreatic β-cell regeneration. The results of statistics analysis 
showed no association between GLP-1 with GLUT-2 expression and 
amount of β-cell of pancreas (p>0.05). The results of this study differ 
from the previous studies which stated that GLP-1 might stimulate GLUT-
2 expression, thereby increasing the sensitivity of pancreatic β-cells [21].
Immunohistochemistry analysis of the pancreas (Fig. 1) revealed that 
the diameter of the islets of Langerhans in all experimental groups was 
shorter than the control group. The number of pancreatic β-cells in the 
islets also decreased significantly (Table 4). This change occurs due to 
the administration of STZ which results in damage to β-cells of pancreas. 
After giving the AR for 6 weeks, there was no increasing diameter from 
the islets of Langerhans or the number of pancreatic β-cells. Therefore, 
it was taken together from the data a conclusion that giving AR does not 
provide stimulation for pancreatic β-cell regeneration.
The effects of AR on insulin serum levels
The number of pancreatic β-cells which decreased in the experimental 
group resulted in decreased insulin secretion so that insulin serum 
levels in the experimental groups were lower than the control group. 
In Table 3, it can be seen that insulin serum level in the negative control 
group is lower than the control group. Table 3 shows that giving rice 
diet for 6 weeks cannot increase insulin serum levels, otherwise giving 
AR for 6 weeks can increase insulin serum level in diabetic rats. That 
is because AR has higher levels of RS and fiber than rice, so AR can 
increase GLP-1 higher than rice. Furthermore, GLP-1 stimulates insulin 
secretion [15].
There are several possible mechanisms that correlate the increase in 
serum GLP-1 with insulin serum level, namely: (1) pancreatic β-cell 
protective or prevention of apoptosis [22] and proliferation pancreatic 
β-cells [15] so that the number of the cells increases; (2) stimulating 
GLUT-2 expression [23,24].
The facts obtained from this research showed no significant difference 
in the expression of GLUT-2 and the number of pancreatic β-cells 
between groups although there were differences in GLP-1 serum levels. 
This proves that the stimulation effect on insulin secretion by GLP-1 
was not through increased expression of GLUT-2 or an increase in the 
number of pancreatic β-cell. Hence, the effect of stimulation on insulin 
secretion by GLP-1 was likely through an increase in the number of 
receptors [15,23] or through other mechanisms such as stimulation on 
hexokinase activity [23].
The assumption mechanism for increasing insulin secretion through 
increasing the number of these receptors according to with the 
alleged effects of GLP-1 on insulin secretion occurs through activation 
adenylyl cyclase. This activation resulted in increased cyclic adenosine 
monophosphate and protein kinase A activity. This condition results 
in increased levels of intracellular calcium resulting in an increase 
in exocytosis (secretion) of insulin [25]. Hence, the more receptors 
the more insulin secretions. The effect of AR1 in stimulating insulin 
secretion was stronger than AR2. Administration of AR1 can restore 
insulin serum levels which are almost the same as control group, while 
AR2 increases insulin serum levels but has not been able to return to 
normal levels.
The effects of AR on FBG level in diabetic rats
After getting diet therapy for 6 weeks, FBG level in the negative control and 
rice group has not differ significantly, whereas the AR1 and AR2 groups 
have decreased significantly (Table 5). The decrease in FBG in the AR1 
and AR2 groups could be due to the effect of RS and fiber on AR. RS [19] 
and fiber [11] have the effect of inhibiting the digestion process because it 
can inhibit the activity of digestive enzymes, resulting in more controlled 
blood glucose levels. This statement is consistent with other studies that 
prove fiber plays a role in controlling blood glucose levels. These effects 
associated with barriers to digestion and absorption of carbohydrates [26].
RS [20] and fiber [11] in the large intestine will be fermented by 
microbiota and produce SCFA [27,28]. Furthermore, SCFA stimulates 
GLP-1 secretion, hereafter, GLP-1 stimulates insulin secretion. Increased 
insulin secretion results in a decrease in blood glucose levels.
SCFA also has the effect of inhibiting activity of hormone-sensitive lipase 
in the blood [28] so that there was a decrease in lipolysis; furthermore, 
Table 5: Fasting blood glucose levels pre- and post-induction and post-therapy
Group FBG
Pre-induction Post-induction Post-therapy
Control 93.70±6.3 96.25±04.5 94.95±05.1
Negative control 93.40±6.3 367.75±23.6 303.25±16.8
Rice 94.30±7.6 366.25±26.4 378.00±13.2
AR1 93.50±6.4 366.70±29.8 125.05±12.1
AR2 93.95±6.6 368.50±28.3 152.00±25.4
n=10, values are given as mean±SD, FBG: Fasting blood glucose is measured in mg/dl, AR1: Analog rice 1, AR2: Analog rice 2. SD: Standard deviation
Fig. 1: Histology of the control rat pancreas (a), histology of the 
induced (diabetes mellitus) rat pancreas (b). The red arrows 
indicate the islets of Langerhans, the yellow line indicates the 
diameter the islets, IHC ×400
Control rat Experimental rata b
Table 4: The expression of GLUT-2 and the number of pancreatic β-cells
Group β-cells with expression of GLUT-2 β-cells without expression of GLUT-2 Total β-cell
Control 11.65±5.1 20.15±7.9 31.80±7.3
Negative control 8.45±2.7 8.08±3.0 16.53±5.6
Rice 8.16±2.3 10.76±5.1 18.92±6.8
AR1 7.95±1.8 9.50±2.5 17.45±3.4
AR2 7.55±6.0 10.44±3.7 17.99±4.3
n=10, values are given as mean±SD, GLUT-2: Glucose transporter-2, AR1: Analog rice 1, AR2: Analog rice 2. SD: Standard deviation
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the free fatty acid (FFA) will decrease. Decreasing levels of FFA in the 
blood will increase insulin sensitivity [28] and reduce resistance to 
hexokinase enzyme activity; thereby, glycolysis and glycogenesis will 
increase so that the blood glucose levels decrease [20,27,29]. Because 
AR1 and AR1 contain high RS and fiber, it will be absorbed more slowly. 
Foods that are slower in absorption will have a lower glycemic index 
so that AR1 and AR have the opportunity to be developed into a staple 
food for DM patients.
CONCLUSION
Based on these results, we concluded that AR significantly effective 
in reducing blood glucose level in diabetic rats through stimulation 
of increased GLP-1 and insulin serum levels but does not affect the 
expression of GLUT-2 and the number of pancreatic β-cell. The highlight 
of this study was that AR1 showed a strong effect in reducing blood 
glucose levels so that it has the potential to be developed as a staple 
food substitute for DM patients.
AUTHORS’ CONTRIBUTIONS
The topic of the research came from the first author. All the authors 
have the same contribution in carried out the research, determine the 
research method, collected and analyzed the data, and formatted these 
manuscripts.
CONFLICTS OF INTEREST
The authors declare that there are no potential conflicts of interest 
regarding the publication of this paper.
REFERENCES
1. Paneni F, Cosentino F. Diabetes and Cardiovascular Disease: 
A Guide to Clinical Management. Switzerland: Springer International 
Publishing; 2015.
2. International Diabetes Federation. Diabetes Atlas. 8th ed. 
International Diabetes Federation; 2017. Available from: http://www.
diabetesatlas.org.
3. Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, 
Ohlrogge AW, et al. IDF diabetes atlas: Global estimates of diabetes 
prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract 
2018;138:271-81.
4. Jameson JL, Fauci AS, Kasper DL, Hauser SL, Longo DL, Loscalzo J. 
Harrison’s Principles of Internal Medicine. 20th ed. Newyork: Mc Graw-
Hill’s Education; 2018.
5. Tjay TH, dan Rahardja K. Obat-Obat Penting: Khasiat, Penggunaan 
dan Efek Sampingmya. 7th ed. Jakarta: Gramedia; 2015.
6. Ahola AJ, Forsblom C, Groop PH. Adherence to special diets and its 
association with meeting the nutrient recommendations in individuals 
with Type 1 diabetes. Acta Diabetol 2018;55:843-51.
7. Bhosale A, Thangavelu PD. Effect of lifestyle modification in Type II 
diabetes mellitus individuals. Asian J Pharm Clin Res 2019;12:381-3.
8. Codella R, Terruzzi I, Luzi L. Why should people with Type 1 diabetes 
exercise regularly? Acta Diabetol 2017;54:615-30.
9. Kalsi A, Singh S, Taneja N, Kukal S, Mani S. Current treatments 
for Type 2 diabetes, their side effects and possible complementary 
treatments. Int J Pharm Pharm Sci 2015;7:13-8.
10. Soong YY, Quek RY, Henry CJ. Glycemic potency of muffins made 
with wheat, rice, corn, oat and barley flours: A comparative study 
between in vivo and in vitro. Eur J Nutr 2015;54:1281-5.
11. Bendich A, Deckelbaum RJ. Preventive Nutrition: The Comphrehensip 
Guide for Health Provesionals. 5th ed. Switzerland: Humana Press; 
2015.
12. Subagio A, Windrati WS. Pengaruh komposisi MOCAF (modified 
cassava flour) dan tepung beras pada karakteristik beras cerdas. Pangan 
2012;21:29-38.
13. Srinivasan K, Viswanad B, Asrat L, Kaul CL, Ramarao P. Combination 
of high-fat diet-fed and low-dose streptozotocin-treated rat: A model 
for Type 2 diabetes and pharmacological screening. Pharmacol Res 
2005;52:313-20.
14. Arumugam S, Natesan S. Hypoglycemic effects of Barleria noctiflora 
fractions on high fat fed with low dose streptozotocin induced Type 2 
diabetes in rats. Int J Pharm Pharm Sci 2016;8:193-200.
15. Bhat GA, Khan HA, Alhomida AS, Sharma P, Singh R, Paray BA, 
et al. GLP-I secretion in healthy and diabetic wistar rats in response 
to aqueous extract of Momordica charantia. BMC Complement Altern 
Med 2018;18:162.
16. Fujii H, Iwase M, Ohkuma T, Ogata-Kaizu S, Ide H, Kikuchi Y, et al. 
Impact of dietary fiber intake on glycemic control, cardiovascular risk 
factors and chronic kidney disease in Japanese patients with Type 2 
diabetes mellitus: The Fukuoka diabetes registry. Nutr J 2013;12:159.
17. Kassaian N, Feizi A, Aminorroaya A, Jafari P, Ebrahimi MT, Amini M, 
et al. The effects of probiotics and synbiotic supplementation on glucose 
and insulin metabolism in adults with prediabetes: A double-blind 
randomized clinical trial. Acta Diabetol 2018;55:1019-28.
18. Vidrine K, Ye J, Martin RJ, McCutcheon KL, Raggio AM, Pelkman C, 
et al. Resistant starch from high amylose maize (HAM-RS2) and dietary 
butyrate reduce abdominal fat by a different apparent mechanism. 
Obesity (Silver Spring) 2014;22:344-8.
19. Zaman SA, Sarbini SR. The potential of resistant starch as a prebiotic. 
Crit Rev Biotechnol 2016;36:578-84.
20. Firdaus J, Sulistyaningsih E, Subagio E. Research article resistant 
starch modified cassava flour (MOCAF) improves insulin resistance. 
Asian J Clin Nutr 2018;10:32-6.
21. Bodinham CL, Al-Mana NM, Smith L, Robertson MD. Endogenous 
plasma glucagon-like peptide-1 following acute dietary fibre 
consumption. Br J Nutr 2013;110:1429-33.
22. Ravassa S, Zudaire A, Díez J. GLP-1 and cardioprotection: From bench 
to bedside. Cardiovasc Res 2012;94:316-23.
23. D’Alessio D, Lu W, Sun W, Zheng S, Yang Q, Seeley R, et al. Fasting 
and postprandial concentrations of GLP-1 in intestinal lymph and portal 
plasma: Evidence for selective release of GLP-1 in the lymph system. 
Am J Physiol Regul Integr Comp Physiol 2007;293:R2163-9.
24. Ravassa S, Zudaire A, Carr RD, Díez J. Antiapoptotic effects 
of  in murine HL-1 cardiomyocytes. Am J Physiol Heart Circ 
Physiol 2011;300:H1361-72.
25. Lim S, Eckel RH. Pharmacological treatment and therapeutic 
perspectives of metabolic syndrome. Rev Endocr Metab Disord 
2014;15:329-41.
26. Brockman DA, Chen X, Gallaher DD. Hydroxypropyl methylcellulose, 
a viscous soluble fiber, reduces insulin resistance and decreases fatty 
liver in zucker diabetic fatty rats. Nutr Metab (Lond) 2012;9:100.
27. Deng J, Wu X, Bin S, Li TJ, Huang R, Liu Z, et al. Dietary amylose and 
amylopectin ratio and resistant starch content affects plasma glucose, 
lactic acid, hormone levels and protein synthesis in splanchnic tissues. 
J Anim Physiol Anim Nutr (Berl) 2010;94:220-6.
28. Maki KC, Pelkman CL, Finocchiaro ET, Kelley KM, Lawless 
AL, Schild AL, et al. Resistant starch from high-amylose maize 
increases insulin sensitivity in overweight and obese men. J Nutr 
2012;142:717-23.
29. Rodwell VW, Bender DA, Botham KM, Kennelly PJ, Weil PA. 
Harper’s Illustrated Biochemistry. 30th ed. New York: McGraw-Hill 
Education; 2015.
